Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (002932.SZ)

CNY 18.76

(-0.74%)

Market Cap (In CNY)

4.18 Billion

Revenue (In CNY)

749.53 Million

Net Income (In CNY)

74.92 Million

Avg. Volume

1.64 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
14.81-23.33
PE
-
EPS
-
Beta Value
0.611
ISIN
CNE1000033Q7
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Ms. Chen Li Li
Employee Count
-
Website
https://www.mdeasydiagnosis.com
Ipo Date
2018-07-10
Details
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. engages in the research and development, production, and sale of in vitro diagnostic reagents and diagnostic equipment in China and internationally. Its products portfolio includes molecular diagnostic products, such as drug metabolism genetic testing and pathogen nucleic acid detection kits; and immunodiagnostic and blood gas diagnosis products. The company also provides emergency and critical illness information solutions, including information software products, supporting hardware, and certification consulting services; and third-party medical inspection services. It offers products in the areas of cardiovascular, kidney, infectious, diabetes, endocrine and metabolic, obstetrics, and gynecology diseases, as well as prenatal and postnatal care, health checkups, thyroid, hormones, blood gas, coagulation, drug metabolism, pathogen detection. The company was founded in 2008 and is based in Wuhan, China.